$664 Thousand is the total value of COMMODORE CAPITAL LP's 35 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 56.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XENE | Buy | XENON PHARMACEUTICALS INC | $65,419 | -99.9% | 1,659,111 | +4.0% | 9.86% | +6.5% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $59,009 | -99.9% | 2,020,166 | -25.1% | 8.89% | 0.0% |
| COGT | COGENT BIOSCIENCES INC | $49,939 | -99.9% | 4,319,940 | 0.0% | 7.53% | -27.4% | |
| BLU | Buy | BELLUS HEALTH INC NEW | $43,595 | -99.9% | 5,303,557 | +3.4% | 6.57% | -24.6% |
| MRUS | Buy | MERUS N V | $42,273 | -99.9% | 2,732,567 | +4.5% | 6.37% | -24.4% |
| CBAY | CYMABAY THERAPEUTICS INC | $35,980 | -99.8% | 5,738,500 | 0.0% | 5.42% | +67.9% | |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $29,615 | -99.9% | 1,880,286 | -22.0% | 4.46% | -26.8% |
| AKRO | Sell | AKERO THERAPEUTICS INC | $29,432 | -99.9% | 537,076 | -27.8% | 4.44% | +9.0% |
| New | NUVALENT INC | $27,208 | – | 913,621 | +100.0% | 4.10% | – | |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $22,099 | -99.9% | 495,823 | -8.0% | 3.33% | +36.8% |
| IMVT | New | IMMUNOVANT INC | $20,421 | – | 1,150,505 | +100.0% | 3.08% | – |
| ARWR | Buy | ARROWHEAD PHARMACEUTICALS IN | $18,743 | -99.9% | 462,111 | +14.4% | 2.82% | +31.6% |
| CELC | Buy | CELCUITY INC | $18,605 | -99.8% | 1,327,952 | +44.3% | 2.80% | +88.7% |
| New | ARCELLX INC | $18,323 | – | 591,437 | +100.0% | 2.76% | – | |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $17,521 | -99.9% | 688,445 | -6.7% | 2.64% | -7.4% |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | $15,918 | -99.9% | 739,661 | 0.0% | 2.40% | +0.7% | |
| RXDX | New | PROMETHEUS BIOSCIENCES INC | $13,987 | – | 127,156 | +100.0% | 2.11% | – |
| ALLK | ALLAKOS INC | $13,838 | -99.9% | 1,643,500 | 0.0% | 2.08% | +28.9% | |
| KURA | Buy | KURA ONCOLOGY INC | $13,644 | -99.9% | 1,099,407 | +22.2% | 2.06% | +4.0% |
| FDMT | New | 4D MOLECULAR THERAPEUTICS IN | $13,290 | – | 598,385 | +100.0% | 2.00% | – |
| RNA | New | AVIDITY BIOSCIENCES INC | $13,108 | – | 590,705 | +100.0% | 1.98% | – |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $10,397 | -99.8% | 223,494 | +115.9% | 1.57% | +81.6% |
| IMRA | New | IMARA INC | $10,204 | – | 2,494,794 | +100.0% | 1.54% | – |
| ALPN | ALPINE IMMUNE SCIENCES INC | $9,739 | -99.9% | 1,325,000 | 0.0% | 1.47% | -4.3% | |
| ETNB | New | 89BIO INC | $9,652 | – | 758,244 | +100.0% | 1.46% | – |
| CABA | New | CABALETTA BIO INC | $9,346 | – | 1,010,359 | +100.0% | 1.41% | – |
| PCVX | New | VAXCYTE INC | $8,318 | – | 173,481 | +100.0% | 1.25% | – |
| KPTI | KARYOPHARM THERAPEUTICS INC | $6,581 | -99.9% | 1,935,609 | 0.0% | 0.99% | -41.6% | |
| Sell | THIRD HARMONIC BIO INC | $4,271 | -100.0% | 993,294 | -2.5% | 0.64% | -79.3% | |
| LRMR | LARIMAR THERAPEUTICS INC | $3,098 | -99.9% | 750,000 | 0.0% | 0.47% | +21.0% | |
| ABOS | Sell | ACUMEN PHARMACEUTICALS INC | $2,691 | -100.0% | 498,315 | -54.7% | 0.41% | -77.1% |
| IMUX | Buy | IMMUNIC INC | $2,520 | -99.9% | 1,800,000 | +101.6% | 0.38% | -16.3% |
| RZLT | REZOLUTE INC | $2,505 | -99.9% | 1,210,000 | 0.0% | 0.38% | -29.1% | |
| KALV | KALVISTA PHARMACEUTICALS INC | $2,113 | -100.0% | 312,553 | 0.0% | 0.32% | -56.4% | |
| DBVT | New | DBV TECHNOLOGIES S Asponsored adr | $142 | – | 92,687 | +100.0% | 0.02% | – |
| TERN | Exit | TERNS PHARMACEUTICALS INC | $0 | – | -205,870 | -100.0% | -0.20% | – |
| BLSA | Exit | BCLS ACQUISITION CORP | $0 | – | -250,000 | -100.0% | -0.40% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -467,468 | -100.0% | -0.50% | – |
| TCDA | Exit | TRICIDA INC | $0 | – | -1,975,403 | -100.0% | -3.33% | – |
| STSA | Exit | SATSUMA PHARMACEUTICALS INC | $0 | – | -3,711,286 | -100.0% | -3.58% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -893,646 | -100.0% | -6.96% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 12 | Q3 2023 | 10.3% |
| COGENT BIOSCIENCES INC | 12 | Q3 2023 | 10.4% |
| VIRIDIAN THERAPEUTICS INC | 11 | Q3 2023 | 8.9% |
| CYMABAY THERAPEUTICS INC | 11 | Q2 2023 | 5.4% |
| KURA ONCOLOGY INC | 11 | Q3 2023 | 7.1% |
| CELLDEX THERAPEUTICS INC NEW | 11 | Q3 2023 | 3.8% |
| ACLARIS THERAPEUTICS INC | 10 | Q1 2023 | 10.4% |
| CELCUITY INC | 10 | Q3 2023 | 7.3% |
| KALVISTA PHARMACEUTICALS INC | 10 | Q2 2023 | 2.2% |
| MERUS N V | 9 | Q3 2023 | 12.5% |
View COMMODORE CAPITAL LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ambrx Biopharma Inc. | April 27, 2023 | 31,181,983 | 8.1% |
| BELLUS Health Inc. | March 30, 2023 | 6,579,359 | 5.2% |
| IMARA Inc. | February 21, 2023 | 2,840,754 | 10.8% |
| Karyopharm Therapeutics Inc. | February 14, 2023 | 1,935,609 | 1.7% |
| VistaGen Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Satsuma Pharmaceuticals, Inc.Sold out | November 16, 2022 | 0 | 0.0% |
| GENOCEA BIOSCIENCES, INC. | February 14, 2022 | 3,079,756 | 5.4% |
View COMMODORE CAPITAL LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-19 |
| SC 13G | 2024-03-21 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View COMMODORE CAPITAL LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.